Insider buying last 90 days
No open-market insider purchases were filed for LDOS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every LDOS insider filing, plotted on the chart in Gekko.Open LDOS in Gekko
NYSE: LDOS
Leidos (LDOS) Stock Analysis & Forecast
Sep 28 close
$122.35−1.26 (−1.0%)
Gekko Brief
AI summaryLeidos slipped this week, closing at $122.35 on 28 September, down about 1% on the day, after trading near $123.35 and $124.73 in the prior sessions. The move follows the company's Q2 2026 earnings call, which detailed record revenue of $4.56 billion, up 7% year over year, a 13.8% adjusted EBITDA margin, and raised full-year guidance for revenue, EPS and operating cash flow. Leidos also secured a $127 million U.S. defense contract, part of continued award activity described on the call, including a 1.1 book-to-bill for the quarter and $5 billion of net awards.
The stock trades well below both its 50-day average of $129.38 and its 200-day average of $148.59, with the shorter average also under the longer one, reflecting a sustained downtrend; the 1-month return stands at -12.5% and the 1-year return at -32.9%. The GekkoIndex reads 65.8, placing Leidos in the Accumulation zone. Price sits 44.7% below the Gekko Fair Value of $221.36.
The next earnings date falls on 3 November 2026, 35 days out, beyond a typical 20-trading-day holding window. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days from this point in the calendar have averaged a 3.9% return over 5 years, positive in 4 of them. Analyst consensus among 13 firms shows 4 buy and 9 hold ratings, with a consensus target of $157.27.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Leidos price vs fair value
Close $122.35200-day averageGekko Fair Value $221.36
Leidos quick facts
- Market cap
- $15.39B
- P/E ratio
- 11.6
- Forward P/E
- 9.6
- EPS, TTM
- $10.60
- Revenue, TTM
- $17.63B
- Profit margin
- 7.8%
- Dividend yield
- 1.36%
- Beta
- 0.57
- Volume
- 961,238 avg 1.29M
- 1-year return
- −32.9%
- Typical daily move
- ±2.8%
- Typical 20-day move
- ±5.3%
- 50-day average
- $129.38
- 200-day average
- $148.59
- Next earnings
- Nov 3 before open
- Shares outstanding
- 125.5M
Leidos swing-trade checklist
Leidos scores 4 supportive, 0 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $122.35 is below the 50-day ($129.38) and 200-day ($148.59) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
65.8, Accumulation
Reading 65.8 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
44.7% below
Price is 44.7% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+3.9% on average
From this point in the calendar, the next 20 trading days averaged +3.9% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Leidos stock chart and price history
Leidos closed at $122.35 on Sep 28, 2026, −32.9% over the past year, inside a 52-week range of $98.86 to $205.77.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −12.5%
- 3 months
- +21.8%
- 6 months
- −21.3%
- 1 year
- −32.9%
The full LDOS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open LDOS in Gekko
Follow Leidos through every session
Put LDOS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track LDOS in GekkoFree for 7 days. No credit card required.
About Leidos
Leidos supplies technology and engineering services to government bodies and commercial organizations working in defense, intelligence, civil administration and health. Clients include branches of the U.S. military, the Department of Defense, NASA, the intelligence community, allied nations abroad, and agencies such as the FAA, along with health-related customers in both public and private sectors. The company is known for pairing large-scale systems work with mission-critical technology across these fields.
Its activities are grouped into three business areas. One builds security and defense systems spanning air, land, sea, space and cyberspace, offering integration, command platforms, analytics, logistics, cybersecurity and operational intelligence support. Another works mainly with air traffic authorities on programs tied to flight data, route automation and airspace monitoring, while also handling IT-related work such as cloud services, network upgrades, help desk support and infrastructure or environmental projects. The third area serves federal and commercial customers with offerings tied to healthcare management, digital health initiatives, and support for scientific research in the life sciences.
Leidos traces its founding back to 1969 and keeps its headquarters in Reston, Virginia. Its stock trades on the NYSE under the ticker LDOS.
- Listed
- NYSE
- Sector
- Technology services
- Industry
- Packaged software
- Website
- leidos.com
Leidos GekkoIndex: the smart money zone
Leidos’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.8, in the Accumulation zone, up 2.2 points over five sessions.
65.8Accumulation
Up 2.2 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days |
|---|---|---|---|
| Buying | 35 | −1.0% | +1.5% |
| Accumulation (current zone) | 209 | −0.5% | −1.3% |
| Neutral | 331 | +0.6% | +2.4% |
| Distribution | 83 | +0.4% | 0.0% |
| Selling | 14 | +2.3% | +3.5% |
Average LDOS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the LDOS price, zone by zone.Track LDOS in Gekko
Is Leidos stock overvalued? Gekko Fair Value
Leidos trades 44.7% below Gekko Fair Value of $221.36, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Leidos shares are worth, recalculated every trading day.
$221.36
Gekko Fair Value, Sep 26, 2026
44.7% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open LDOS in Gekko
Leidos insider and Congress trading
No open-market insider purchases were filed for Leidos, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in LDOS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for LDOS, plotted on the chart in Gekko.Open LDOS in Gekko
Buybacks
Leidos has been buying back its own shares.
- Bought back, quarter ended Jul 3, 2026
- $72.00M
- As a share of market cap
- 0.47%
- Trailing four quarters
- $722.0M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold LDOS.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Leidos earnings: next date and track record
Leidos reports on Nov 3, 2026, before the open (35 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 3, 2026
Expected before the open, 35 days away
- EPS estimate
- $3.00
- Revenue estimate
- $4.72B
8 of 8reports beat the EPS estimate
±5.8%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 4, 2026 AI summary
- What they said
- Leidos reported a strong Q2 FY2026 with record revenue of $4.56 billion (up 7% y/y, 4% organic), adjusted EBITDA margin of 13.8%, and record operating cash flow (~$793 million). Management highlighted a 1.1 book-to-bill for the quarter and $5 billion of net awards. Defense and Homeland were key growth drivers: Defense posted a 2.2 book-to-bill in Q2 and management cited accelerating award velocity and several major defense tech program opportunities (munitions, unmanned surface vessel, missile warning payloads). Health contracted due to the full incorporation of a fourth vendor on the VBA Medical Disability Examination (MDE) regions contract and a temporary pause of incentive payments; management expects extensions and a draft RFP soon and remains confident in its ability to re-secure the business. Management raised the midpoint of 2026 revenue guidance by $100 million, EPS midpoint by $0.05, and operating cash flow guidance by $50 million; free cash flow outlook was elevated after a strong quarter and lower-than-expected CapEx. Capital allocation remains balanced across investment in Defense Tech, enterprise needs, share repurchases (new authorization), and M&A (disciplined).
- Guidance
- Raised midpoint of 2026 revenue guidance by $100 million; raised midpoint of EPS guidance by $0.05; raised operating cash flow guidance by $50 million. Management also signaled elevated full-year free cash flow expectations (after Q2 results and reduced CapEx), and second-half organic growth guidance implied roughly ~4-4.5% (management commentary).
- Risks flagged
- Temporary removal of VBA incentive payments and uncertainty around the MDE recompete (timing/terms) that could pressure Health revenue and margins; trend toward in-sourcing by government customers reducing systems-integration scope; potential federal funding timing risks (continuing resolutions) that could affect Intel & Digital bookings near fiscal year-end; M&A valuation mismatch and capital deployment uncertainty; execution risks on scaling Defense Tech (manufacturing, program execution).
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $3.26 est $2.90 | $4.56B est $4.44B | +6.8% |
| May 5, 2026 | $3.13 est $2.91 | $4.40B est $4.28B | −9.3% |
| Feb 17, 2026 | $2.76 est $2.61 | $4.21B est $4.30B | −2.7% |
| Nov 4, 2025 | $3.05 est $2.71 | $4.47B est $4.28B | +1.0% |
| Aug 5, 2025 | $3.21 est $2.66 | $4.25B est $4.23B | +8.4% |
| May 6, 2025 | $2.97 est $2.50 | $4.25B est $4.09B | +4.6% |
| Feb 11, 2025 | $2.37 est $2.28 | $4.37B est $4.13B | −4.1% |
| Oct 29, 2024 | $2.93 est $2.02 | $4.19B est $4.06B | +9.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Leidos stock forecast and analyst price targets
Analysts’ average 12-month price target for Leidos is $157.27, +28.5% from the last close, from 13 firms rating the stock in the last 90 days.
$157.27consensus 12-month target, +28.5% from the last close
Now $122.35Avg $157.27
Low $132High $170
Each firm’s latest rating in the last 90 days: 13 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Bank of America Securities | $135 | +10.3% |
| Sep 18 | Bank of America Securities | $135 | +10.3% |
| Sep 7 | TD Cowen | $135 | +10.3% |
| Aug 14 | Wells Fargo | $165 | +34.9% |
| Aug 11 | Goldman Sachs | $132 | +7.9% |
−1.3%average 20-day move after past Accumulation readings
+3.9%average move over the next 20 trading days in the last 5 years
±2.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Leidos seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Leidos averaged +3.9% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.5% | 3 of 5 |
| Next 10 trading days | +2.3% | 5 of 5 |
| Next 15 trading days | +3.6% | 5 of 5 |
| Next 20 trading days | +3.9% | 4 of 5 |
| Next 30 trading days | +12.1% | 4 of 5 |
For scale, LDOS’s typical 20-trading-day move in either direction is about 5.3%.
Leidos market cap and key statistics
Leidos’s market cap is $15.39B, with a P/E ratio of 11.6 and revenue of $17.63B over the last twelve months.
Valuation
- Market cap
- $15.39B
- P/E ratio
- 11.6
- Forward P/E
- 9.6
- EPS, TTM
- $10.60
- Gekko Fair Value
- $221.36
Trading
- Volume
- 961,238
- Avg volume, 20 days
- 1.29M
- 52-week high
- $205.77
- 52-week low
- $98.86
- Shares outstanding
- 125.5M
Financials
- Revenue, TTM
- $17.63B
- Profit margin
- 7.8%
- Return on equity
- 27.8%
- Quarterly earnings growth, YoY
- −6.7%
Risk and income
- Beta
- 0.57
- Typical daily move
- ±2.8%
- Typical 20-day move
- ±5.3%
- Dividend yield
- 1.36%
Leidos stock news this week
Coverage of Leidos this week reads positive: 13 positive, 4 neutral and 2 negative headlines.
- Leidos stock last trades at USD 122.35 on September 28, 2026, down 1.02 percentAD HOC NEWS, Sep 28
- Leidos Holdings, Inc. $LDOS Stock Position Cut by Corient Private Wealth LPMarketBeat, Sep 26
- Leidos Holdings Inc. stock outperforms competitors despite losses on the dayMarketWatch, Sep 25
- Full Transcript: Leidos Holdings Q2 2026 Earnings CallBenzinga, Sep 25
- Leidos Holdings stock heads into the open after closing at USD 196.84AD HOC NEWS, Sep 25
- Leidos Holdings, Inc. (LDOS.MX) Stock Price, News, Quote & HistoryYahoo! Finance Canada, Sep 24
Leidos peers
Leidos’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.3% above |
| PLTRPalantir Technologies | Neutral | 15.7% above |
| ORCLOracle | Accumulation | 25.9% below |
| PANWPalo Alto Networks | Neutral | 16.1% above |
| CRWDCrowdStrike | Neutral | 27.2% above |
| CRMSalesforce | Neutral | 5.9% below |
A peer links to its own page where one exists.
Leidos stock FAQ
What is Leidos’s market cap?
Leidos’s market cap is $15.39B at the Sep 28, 2026 close of $122.35, with 125.5M shares outstanding. The shares trade on a P/E ratio of 11.6.
What is the Leidos stock forecast?
The consensus analyst 12-month price target for Leidos is $157.27, +28.5% from the last close. Of the 13 firms that rated the stock in the last 90 days, 4 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Leidos stock overvalued or undervalued?
On Gekko’s estimate Leidos is undervalued: the Sep 28, 2026 close of $122.35 is 44.7% below Gekko Fair Value of $221.36. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Leidos report earnings next?
Leidos is expected to report on Nov 3, 2026, before the market opens (35 days away). Analysts expect earnings of $3.00 per share on revenue of $4.72B. Leidos beat the earnings estimate in 8 of its last 8 reports, moving 5.8% on average across the report.
What is Leidos’s 52-week high and low?
Leidos’s 52-week high is $205.77 and its 52-week low is $98.86; it closed at $122.35 on Sep 28, 2026, −32.9% over the past year.
Is Leidos stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Leidos the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.